Cardinal Health
Pharmaceuticals
CAH
$ 76 (1.8)%
Share price
$ 20 bn
Market Cap
$ 22 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Cardinal Health aims to reduce Scope 1 + 2 by 50% by 2030 from a base year 2019
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
Cardinal Health reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 421 Kt (-22 /-4.9% y-o-y). Also positively, carbon intensity was down at 2.6 t (-0.3 /-10.3% y-o-y).
Cardinal Health's Scope 3 emissions plummeted to 2.5 Kt (
The company is committed to reducing Scope 1 + 2 by 50% by 2030 from a base year 2019, which translates into the estimated reduction of -18 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2023 Exerica. All rights reserved.